Edition:
United States

Insider Trading: Alkermes Plc (ALKS.O)

ALKS.O on Nasdaq

51.40USD
10:25am EDT
Change (% chg)

$-0.16 (-0.31%)
Prev Close
$51.56
Open
$51.52
Day's High
$51.64
Day's Low
$51.35
Volume
68,968
Avg. Vol
805,847
52-wk High
$63.40
52-wk Low
$41.93

EHRICH ELLIOT W

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 396
Total Shares Held: 155,734,547
3 Mo. Net Change: 2,737,824
# New Positions: 33
# Closed Positions: 41
# Increased Positions: 164
# Reduced Positions: 149
# Net Buyers: 15

Officers & Directors

Name Age Since Current Position

Richard Pops

55 2011 Chairman of the Board, Chief Executive Officer

Shane Cooke

54 2011 President

James Frates

49 2011 Chief Financial Officer, Senior Vice President, Treasurer

Kathryn Biberstein

58 2017 Executive Vice President, Chief Administrative Officer, Chief Compliance Officer, Chief Risk Officer, Secretary

Elliot Ehrich

57 2015 Executive Vice President - Research and Development and Chief Medical Officer

Iain Brown

48 2016 Senior Vice President - Finance, Chief Accounting Officer

David Gaffin

45 2016 Senior Vice President, Chief Legal Officer

Craig Hopkinson

2017 Senior Vice President - Clinical Development and Medical Affairs, Chief Medical Officer

Michael Landine

63 2011 Senior Vice President - Corporate Development

Mark Stejbach

53 2012 Senior Vice President, Chief Commercial Officer

Paul Mitchell

64 2012 Lead Independent Director

David Anstice

68 2011 Independent Director

Floyd Bloom

80 2011 Independent Director

Robert Breyer

73 2011 Independent Director

Wendy Dixon

61 2011 Independent Director

Nancy Snyderman

58 2016 Independent Director

Nancy Wysenski

59 2017 Independent Director